Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion type Assertion NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_head.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion wasGeneratedBy ECO_0000203 NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_provenance.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion wasDerivedFrom befree-20140225 NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_provenance.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion SIO_000772 16849682 NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_provenance.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion evidence source_evidence_literature NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_provenance.
- NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_assertion description "[A quantitative fluorogenic real-time polymerase chain reaction (PCR) assay was used to examine primary tumor DNA and urine sediment DNA from 15 patients with bladder cancer and 25 control subjects for promoter hypermethylation of nine genes (APC, ARF, CDH1, GSTP1, MGMT, CDKN2A, RARbeta2, RASSF1A, and TIMP3) to identify potential biomarkers for bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879193.RAD9-epHLN7plAfnZeCtt4VPRrnGPds0lwHKN_pM9fpA8130_provenance.